VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3329
ETF rank
โ‚น1.68 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น2,550
Share price
-0.68%
Change (1 day)
35.10%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of September 2026: 0.35%